Small-molecule cyclin-dependent kinase modulators

Oncogene

Volumn 22, Issue 43, 2003, Pages 6609-6620

  Senderowicz, Adrian M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

BMS 387032; Cell cycle; CYC202; Cyclin dependent kinases; Drug development; Flavopiridol; Molecular targets; UCN 01

Indexed keywords

2 BIS(2 HYDROXYETHYL)AMINO 9 ISOPROPYL 6 (4 METHOXYBENZYLAMINO)PURINE; 7 HYDROXYSTAUROSPORINE; ALSTERPAULLONE; AMINOTHIADIAZOLE; ANTIDIARRHEAL AGENT; ANTINEOPLASTIC AGENT; BUTYROLACTONE; CISPLATIN; COLESTYRAMINE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLAVOPIRIDOL; FLUOROURACIL; GEFITINIB; GEMCITABINE; INDIRUBIN; L 86 8275; LOPERAMIDE; MEVINOLIN; N [5 (5 TERT BUTYL 2 OXAZOLYLMETHYLTHIO) 2 THIAZOLYL]ISONIPECOTAMIDE; OLOMOUCINE; PACLITAXEL; PERIFOSINE; PURVALANOL; ROSCOVITINE; SMALL MOLECULE CYCLIN DEPENDENT KINASE MODULATOR; TAXANE DERIVATIVE; TOPOTECAN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ASTHENIA; BINDING SITE; CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CLINICAL TRIAL; DIARRHEA; DNA DAMAGE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; DRUG TOLERABILITY; ENZYME ACTIVATION; FATIGUE; FEVER; HEAD AND NECK CANCER; HUMAN; HYPERGLYCEMIA; HYPOTENSION; HYPOXEMIA; INFLAMMATION; INSULIN RESISTANCE; KIDNEY CANCER; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; NAUSEA; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROINFLAMMATORY SYNDROME; REVIEW; SECRETORY DIARRHEA; SURVIVAL TIME; TUMOR SUPPRESSOR GENE; VEIN THROMBOSIS; VOMITING;

EID: 0242708738     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206954     Document Type: Review

References (186)

1. Aagaard L, Lukas J, Bartkova J, Kjerulff AA, Strauss M and Bartek J. (1995). Int. J. Cancer, 61, 115-120.
2. Adams J, Palombella VJ and Elliott PJ. (2000). Invest. New Drugs, 18, 109-121.
3. Akinaga S, Gomi K, Morimoto M, Tamaoki T and Okabe M. (1991). Cancer Res, 51, 4888-4892.
4. Akinaga S, Nomura K. Gomi K and Okabe M. (1993). Cancer Chemother. Pharmacol., 32, 183-189.
5. Akinaga S, Nomura K, Gomi K and Okabe M. (1994). Cancer Chemother. Pharmacol., 33, 273-280.
6. Akiyama T, Shimizu M, Okabe M, Tamaoki T and Akinaga S. (1999). Anticancer Drugs, 10, 67-78.
7. Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M and Akinaga S. (1997). Cancer Res., 57, 1495-1501.
8. An HX, Beckmann MW, Reifenberger G, Bender HG and Niederacher D. (1999). Am. J. Pathol., 154, 113-118.
9. Arguello F, Alexander M, Sterry J, Tudor G, Smith E, Kalavar N, Greene J, Koss W, Morgan D, Stinson S, Siford T, Alvord W, Labansky R and Sausville E. (1998). Blood, 91, 2482-2490.
10. Baratte B, Meijer L, Galaktionov K and Beach D. (1992). Anticancer Res., 12, 873-880.
11. Bartek J, Staskova Z, Draetta G and Lukas J. (1993). Stem Cells (Dayt), 11 (Suppl. 1), 51-58.
12. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J and Bartek J. (1996). Cancer Res., 56, 5475-5483.
13. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J. (1995). Cancer Res., 55, 949-956.
14. Bennett S, Mani S, O'Reilly S, Wright J, Schilsky R, Vokes E and Grochow L. (1999). Proc. Am. Soc. Clin. Oncol., 18, 156.
15. Bible KC and Kaufmann SH. (1996). Cancer Res., 56, 4856-4861.
16. Bible KC and Kaufmann SH. (1997). Cancer Res., 57, 3375-3380.
17. Blanchard JL, Epstein DM, Boisclair MD, Rudolph J and Pal K. (1999). Bioorg. Med. Chem. Lett., 9, 2537-2538.
18. Bonfanti M, Taverna S, Salmona M, D'Incalci M and Broggini M. (1997). Cancer Res., 57, 1442-1446.
19. Bramson HN, Corona J, Davis ST, Dickerson SH, Edelstein M, Frye SV, Gampe Jr RT, Harris PA, Hassell A, Holmes WD, Hunter RN, Lackey KE, Lovejoy B, Luzzio MJ, Montana V, Rocque WJ, Rusnak D, Shewchuk L, Veal JM, Walker DH and Kuyper LF. (2001). J. Med. Chem., 44, 4339-4358.
20. Brooks EE, Gray NS, Joly A, Kerwar SS, Lum R, Mackman RL, Norman TC, Rosete J, Rowe M, Schow SR, Schultz PG, Wang X, Wick MM and Shiffman D. (1997). J. Biol. Chem., 272, 29207-29211.
21. Brusselbach S, Nettelbeck DM, Sedlacek HH and Muller R. (1998). Int. J. Cancer, 77, 146-152.
22. Bunch RT and Eastman A. (1996). Clin. Cancer Res., 2, 791-797.
23. Bunch RT and Eastman A. (1997). Cell Growth Differ., 8, 779-788.
24. Buquet-Fagot C, Lallemand F, Montagne M and Mester J. (1997). Anti-Cancer Drugs, 8, 623-631.
25. Busby EC, Leistritz DF, Abraham RT, Karnitz LM and Sarkaria JN. (2000). Cancer Res., 60, 2108-2112.
26. Byrd JC, Shinn, C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E and Grever MR. (1998). Blood, 92, 3804-3816.
27. Cagnoli M. Barbieri F, Bruzzo C and Alama A. (1998). Gynecol. Oncol., 70, 372-377.
28. Carlson BA, Dubay MM, Sausville EA, Brizuela L and Worland PJ, (1996b). Cancer Res., 56, 2973-2978.
29. Carlson B, Lahusen T, Singh S, Loaiza-Perez A, Worland PJ, Pestell R, Albanese C, Sausville EA and Senderowicz AM. (1999). Cancer Res., 59, 4634-4641.
30. Carlson B, Pearlstein R, Naik R, Sedlacek H, Sausville E and Worland P. (1996a). Proc. Am. Assoc. Cancer Res., 37, 424.
31. Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, Peterlin BM and Price DH. (2000). J. Biol. Chem., 275, 28345-28348.
32. Chen X, Lowe M and Keyomarsi K. (1999a). Oncogene, 18, 5691-5702.
33. Chen YN, Sharma SK, Ramsey TM, Jiang L, Martin MS, Baker K, Adams PD, Bair KW and Kaelin Jr WG. (1999b). Proc. Natl. Acad. Sci. USA, 96, 4325-4329.
34. Chien M. Astumian M, Liebowitz D, Rinker-Schaeffer C and Stadler W. (1999). Cancer Chemother Pharmacol., 44, 81-87.
35. Chintala SK, Fueyo J, Gomez-Manzano C, Venkaiah B, Bjerkvig R, Yung WK, Sawaya R, Kyritsis AP and Rao JS. (1997). Oncogene, 15, 2049-2057.
36. Choi YH, Lee, SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkart PA and Trepel JB. (1997). J. Biol. Chem., 272, 28479-28484.
37. Colas P, Cohen B, Jessen T, Grishina I, McCoy J and Brent R. (1996). Nature, 380, 548-550.
38. Craig C, Wersto R, Kim M, Ohri E, Li Z, Katayose D, Lee SJ, Trepel J, Cowan K and Seth P. (1997). Oncogens, 14, 2283-2289.
39. De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M and Kim SH. (1997). Eur. J. Biochem., 243, 518-526.
40. De Azevedo Jr WF. Mueller-Dieckmann HJ, Schulze-Gahmen U, Worland PJ, Sausville E and Kim SH. (1996). Proc. Natl. Acad. Sci. USA, 93, 2735-2740.
41. Dees E, O'Reilly S, Figg W, Elza-Brown K, Aylesworth C, Carducci M, Byrd J, Grever M and Donehower R. (2000). Proc. Am. Soc. Clin. Oncol., 19, 154.
42. DeGregori J, Leone G, Ohtani K, Miron A and Nevins JR. (1995). Genes Dev., 9, 2873-2887.
43. Dermatakis A, Luk KC and DePinto W. (2003). Bioorg. Med. Chem., 11, 1873-1881.
44. Dodo K, Takahashi M, Yamada Y, Sugimoto Y, Hashimoto Y and Shirai R. (2000). Bioorg. Med. Chem. Lett., 10, 615-617.
45. Drees M, Dengler W, Roth T, Labonte H, Mayo J, Malspeis L, Grever M, Sausville E and Fiebig H. (1997). Clin. Cancer Res., 32, 273-279.
46. Driscoll B, Buckley S, Barsky L, Weinberg K, Anderson KD and Warburton D. (1999). Am. J. Physiol., 276, L679-L687.
47. Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G, Connell-Crowley L, Elledge SJ, Zhang WW and Harper JW et al (1995). Cancer Res., 55, 5151-5155.
48. Eicher SA, dayman GL, Liu TJ, Shillitoe EJ, Storthz KA, Roth JA and Lotan R. (1996). Clin. Cancer Res., 2, 1659-1664.
49. Fahraeus R, Paramio JM, Ball KL, Lain S and Lane DP. (1996). Curr. Biol., 6, 84-91.
50. Fingert HJ, Pu AT, Chen ZY, Googe PB, Alley MC and Pardee AB. (1988). Cancer Res., 48, 4375-4381.
51. Fowler L, Dong L, Bowes III RC, van de Water B, Stevens JL and Jaken S. (1998). Cell Growth Differ., 9, 177-184.
52. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O Hare MJ and Lu X. (1997). Proc. Natl. Acad. Sci. USA. 94, 6380-6385.
53. Fry DW, Bedford DC, Harvey PH, Fritsch A, Keller PR, Wu Z, Dobrusin E, Leopold WR. Fattaey A and Garrett MD. (2001). J. Biol Chem., 276, 16617-16623.
54. Fuse E, Tanii H, Kurata N, Kobayashi H, Shimada Y, Tamura T, Sasaki Y, Tanigawara Y, Lush RD, Headlee D, Figg W, Arbuck SG, Senderowicz AM, Sausville EA, Akinaga S, Kuwabara T and Kobayashi S. (1998). Cancer Res., 58, 3248-3253.
55. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N and Beger HG. (1997). Cancer Res., 57, 1634-1637.
56. Gius DR, Ezhevsky SA. Becker-Hapak M, Nagahara H, Wei MC and Dowdy SF. (1999). Cancer Res., 59, 2577-2580.
57. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM and Piwnica-Worms H. (2000). J. Biol. Chem., 275, 5600-5605.
58. Gray-Bablin J, Rao S and Keyomarsi K. (1997). Cancer Res., 57, 604-609.
59. Gray N, Detivaud L, Doerig C and Meijer L. (1999). Curr. Med. Chem., 6, 859-875.
60. Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, LeClerc S, Meijer L, Kim SH, Lockhart DJ and Schultz PG. (1998). Science, 281, 533-538.
61. Hashemolhosseini S, Nagamine Y, Morley SJ, Desrivieres S, Mercep L and Ferrari S. (1998). J. Biol. Chem., 273, 14424-14429.
62. Hatakeyama M and Weinberg RA. (1995). Prog. Cell Cycle Res., 1, 9-19.
63. Hsueh CT, Reisen D and Schwartz GK. (1998). Clin. Cancer Res., 4, 2201-2206.
64. Hunter T and Pines J. (1994). Cell, 79, 573-582.
65. Husain A, Yan XJ, Resales N, Aghajanian C, Schwartz GK and Spriggs DR. (1997). Clin. Cancer Res., 3, 2089-2097.
66. Ichimura K, Schmidt EE, Goike HM and Collins VP. (1996). Oncogens. 13, 1065-1072.
67. Innocenti F, Stadler WM, Iyer L, Ramirez J, Vokes E and Ratain M. (2000). Clin. Cancer Res., 6, 3400-3405.
68. Jacks T and Weinberg RA. (1998). Science, 280, 1035-1036.
69. Jeong HW, Kim MR, Son KH, Han MY, Ha JH, Gamier, M, Meijer L and Kwon BM. (2000). Bioorg. Med. Chem. Lett., 10, 1819-1822.
70. Jin X, Nguyen D, Zhang WW, Kyritsis AP and Roth JA. (1995). Cancer Res., 55, 3250-3253.
71. Jones CB, Clements MK, Wasi S and Daoud SS. (2000). Cancer Chemother. Pharmacol., 45, 252-258.
72. Kanoe H, Nakayama T, Murakami H, Hosaka T, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Sasaki MS and Toguchida J. (1998). Anticancer Res., 18, 2317-2321.
73. Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH and Seth P. (1997). Cancer Res., 57, 5441-5445.
74. Kaur G, Stetler-Stevenson M, Sebers S, Worland P. Sedlacek H, Myers C, Czech J, Naik R and Sausville E. (1992). J. Natl. Cancer Inst., 84, 1736-1740.
75. Kawakami K, Futami H, Takahara J and Yamaguchi K. (1996). Biochem. Biophys. Res. Commun., 219, 778-783.
76. Kent LL, Hull-Campbell NE, Lau T, Wu JC, Thompson SA and Nori M, (1999). Biochem. Biophys. Res. Commun., 260, 768-774.
77. Kerr JS, Wexler RS, Mousa SA, Robinson CS, Wexler EJ, Mohamed S, Voss ME, Devenny JJ, Czerniak PM, Gudzelak Jr A and Slee AM. (1999). Anticancer Res., 19, 959-968.
78. Kim KS, Kimball SD, Misra RN, Rawlins DB, Hunt JT, Xiao HY, Lu S, Qian L, Han WC, Shan W, Mitt T, Cai ZW, Poss MA, Zhu H, Sack JS, Tokarski JS, Chang CY, Pavletich N, Kamath A, Humphreys, WG, Marathe P, Bursuker I, Kellar KA, Roongta U, Batorsky R, Mulheron JG, Bol D, Fairchild CR, Lee FY and Webster KR. (2002). J. Med. Chem., 45, 3905-3927.
79. Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y and Yasuda H et al (1993). Oncogene, 8, 2425-2432.
80. Konig A. Schwartz GK. Mohammad RM, Al-Katib A and Gabrilove JL. (1997). Blood, 90, 4307-41312.
81. Kornmann M, Arber N and Korc M. (1998). J. Clin. Invest., 101, 344-352.
82. Kris M, Natale N, Herbst RS, Lynch Jr TJ. Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis C, Albain KS, Brahmer JR, Sandler A, Crawford J, Lutzker SG, Lilenbaum R, Helms L, Wolf M, Averbuch S, Ochs J and Kay A. (2002). Proc. Am. Soc. Clin. Oncol., 21, 1166.
83. Lahusen T, De Siervi A, Kunick C and Senderowicz AM. (2003). Mol Carcinogen., 36, 183-194.
84. Lahusen J, Loaiza-Perez A, Sausville EA and Senderowicz AM. (2000). Proceedings of the Twentieth Annual Meeting of the American Association of Cancer Research. San Francisco, CA.
85. Lane ME, Yu B, Rice A, Lipson KE, Liang C, Sun L, Tang C, McMahon G, Pestell RG and Wadler S. (2001). Cancer Res., 61, 6170-6177.
86. Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Wu YZ, Mandelkow EM. Eisenbrand G and Meijer L. (2001). J. Biol. Chem., 276, 251-260.
87. Lee HR, Chang TH, Tebalt III MJ, Senderowicz AM and Szabo E. (1999). Int. J. Oncol., 15, 161-166.
88. Lees JA. Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N and Helin K. (1993). Mol. Cell Biol., 13, 7813-7825.
89. Losiewicz MD, Carlson BA, Kaur G, Sausville EA and Worland PJ. (1994). Biochem. Biophys. Res. Commun., 201, 589-5895.
90. Lowe SW, Bodis S, Bardeesy N, McClatchey A, Remington L, Ruley HE, Fisher DE, Jacks T, Pelletier J and Housman DE. (1994). Cold Spring Harbor Symp. Quant. Biol., 59, 419-426.
91. Lukas J, Aagaard L, Strauss M and Bartek J. (1995a). Cancer Res., 55, 4818-4823.
92. Lukas J, Bartkova J, Rohde M, Strauss M and Bartek J. (1995b). MolI. Cell. Biol., 15, 2600-2611.
93. Marchetti A, Buttitta F, Merlo G, Diella F, Pellegrini S, Pepe S, Macchiarini P, Chella A, Angeletti CA and Callahan R et al (1993). Cancer Res., 53, 2846-2851.
94. Masciullo V, Scambia G. Marone M, Giannitelli C, Ferrandina G, Bellacosa A, Benedetti Panici P and Mancuso S. (1997). Int. J. Cancer, 74, 390-395.
95. McClue SJ, Blake D, Clarke R, Cowan A, Cummings L, Fischer PM, MacKenzie M, Melville J, Stewart K, Wang S, Zhelev N, Zheleva D and Lane DP. (2002). Int. J. Cancer, 102, 463-468.
96. Meijer L. (2000). Drug Resist. Updat., 3, 83-88.
97. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG and Moulinoux JP. (1997). Eur. J. Biochem., 243, 527-536.
98. Meijer L and Kim SH. (1997). Methods Enzymol., 283, 113-128.
99. Melillo G, Sausville EA, Cloud K, Lahusen T, Varesio L and Senderowicz AM. (1999). Cancer Res., 59, 5433-5437.
100. Mesguiche V, Parsons RJ, Arris CE, Bentley J, Boyle FT. Curtin NJ, Davies TG, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Jewsbury P, Johnson LN, Newell DR, Noble ME, Wang LZ and Hardcastle IR. (2003). Bioorg. Med. Chem. Lett., 13, 217-222.
101. Mettey Y, Gompel M, Thomas V, Garnier M, Leost M, Ceballos-Picot I, Noble M, Endicott J, Vierfond JM and Meijer L. (2003). J. Med. Chem., 46, 222-236.
102. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A. (1995). Cancer Res., 55, 975-978.
103. Misra RN, Rawlins DB, Xiao H, Shan W, Bursuker I, Kellar KA, Mulheron JG, Sack JS, Tokarski JS, Kimball SD and Webster KR. (2003). Bioorg. Med. Chem. Lett., 13, 1133-1136.
104. Morgan DO. (1997). Annu. Rev. Cell. Dev. Biol., 13, 261-291.
105. Motokura T and Arnold A. (1993). Curr. Opin. Genet. Dev., 3, 5-10.
106. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN and Rosen N. (1998). J. Biol Chem., 273, 29864-29872.
107. Nugiel DA, Etzkorn AM. Vidwans A, Benfield PA, Boisclair M, Burton CR, Cox S, Czerniak PM. Doleniak D and Seitz SP. (2001). J. Med. Chem., 44, 1334-1336.
108. Ortega MA, Montoya ME, Zarranz B, Jaso A, Aldana I, Leclerc S. Meijer L and Monge A. (2002). Bioorg. Med. Chem., 10, 2177-2184.
109. Park S, Cheon J, Lee Y, Park Y, Lee K, Lee C and Lee S. (1996). Mol. Cells, 6, 679-683.
110. Parker B, Kaur G, Nieves-Neira W, Taimi M, Kolhagen G, Shimizu T, Pommier Y, Sausville E and Senderowicz AM. (1998). Blood, 91, 458-465.
111. Patel V, Lahusen T, Leethanakul C, Igishi T, Kremer M, Quintanilla-Martinez L, Ensley JF, Sausville EA. Gutkind JS and Senderowicz AM. (2002a). Clin. Cancer Res., 8, 3549-3560.
112. Patel V, Lahusen T, Sy T, Sausville EA, Gutkind JS and Senderowicz AM. (2002b). Cancer Res., 62, 1401-1409.
113. Patel V, Senderowicz AM, Pinto D, Igishi T, Raffeid M, Quintanilla-Martinez L, Ensley JF, Sausville EA and Gutkind JS. (1998). J. Clin. Invest., 102, 1674-1681.
114. Pollack IF, Kawecki S and Lazo JS. (1996). J. Neurosurg., 84, 1024-1032.
115. Roberge M, Tudan C, Hung SM, Harder KW, Jirik FR and Andersen H. (1994). Cancer Res., 54, 6115-6121.
116. Rubles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH and Conti CJ. (1998). Genes Dev, 12, 2469-2474.
117. Rodriguez-Puebla ML, LaCava M and Conti CJ. (1999). Cell Growth Differ., 10, 467-472.
118. Rosania GR. Merlie Jr J, Gray N, Chang YT, Schultz PG and Heald R. (1999). Proc. Natl Acad. Sci. USA, 96, 4797-4802.
119. Ryu CK, Kang HY, Lee SK, Nam KA, Hong CY, Ko WG and Lee BH. (2000). Bioorg. Med. Chem. Lett., 10, 461-464.
120. Sandig V, Brand K, Herwig S, Lukas J, Bartek J and Strauss M. (1997). Nat. Med., 3, 313-319.
121. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM and Abraham RT. (1999). Cancer Res., 59, 4375-4382.
122. Sato S, Fujita N and Tsuruo T. (2002). Oncogene, 21, 1727-1738.
123. Sausville EA, Arbuck SG, Messmann R, Headlee D, Bauer KS, Lush RM, Murgo A, Figg WD, Lahusen T, Jaken S, Jing X, Roberge M, Fuse E, Kuwabara T and Senderowicz AM. (2001). J. Clin. Oncol., 19, 2319-2333.
124. Sausville EA, Lush RD, Headlee D, Smith AC, Figg WD, Arbuck SG, Senderowicz AM, Fuse E, Tanii H, Kuwabara T and Kobayashi S. (1998). Cancer Chemother. Pharmacol., 42 (Suppl), S54-S59.
125. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J and Johnson DH. (2002). N. Engl. J. Med., 346, 92-98.
126. Schoepfer J, Fretz H, Chaudhuri B, Muller L, Seeber E, Meijer L, Lozach O, Vangrevelinghe E and Furet P. (2002). J. Med. Chem., 45, 1741-1747.
127. Schrump DS. Matthews W, Chen GA, Mixon A and Altorki NK. (1998). Clin. Cancer Res., 4, 2885-2890.
128. Schultz C, Link, A, Leost M, Zaharevitz DW, Gussio R, Sausville EA. Meijer L and Kunick C. (1999). J. Med. Chem., 42, 2909-2919.
129. Schutte B, Nieland L, van Engeland M, Henfling ME, Meijer L and Ramaekers FC. (1997). Exp. Cell. Res., 236, 4-15.
130. Schwartz G, Farsi K, Maslak P, Kelsen D and Spriggs D. (1997). Clin. Cancer Res., 3, 1467-1472.
131. Schwartz GK, O'Reilly E, Ilson D, Saltz L, Sharma S, Tong W. Maslak P. Stoltz M, Eden L, Perkins P, Endres S, Barazzoul J, Spriggs D and Kelsen D. (2002). J. Clin. Oncol., 20, 2157-2170.
132. Sedlacek HH, Czech J, Naik R, Kaur G, Worland P, Losiewicz M, Parker B, Carlson B, Smith A, Senderowicz A and Sausville E. (1996). Int. J. Oncol., 9, 1143-1168.
133. Senderowicz AM. (1999). Invest. New Drugs, 17, 313-320.
134. Senderowicz AM. (2000). Oncogene, 19, 6600-6606.
135. Senderowicz AM. (2001a). Cancer Chemother. Biol. Response Modif., 19, 165-188.
136. Senderowicz AM. (2001b). Cancer Chemother. Biol. Response Modif., 19, 165-188.
137. Senderowicz AM. (2002a). Oncologist, 7, 12-19.
138. Senderowicz AM. (2002b). Hematol. Oncol. Clin. N. Am., 16, 1229-1253.
139. Senderowicz AM, Headlee D, Lush R, Bauer K, Figg W, Murgo A, S, Arbuck S, Inoue K, Kobashi S, Kuwabara T and Sausville E. (1998a). 10th National Cancer Institute-European Organisation for Research on Treatment of Cancer Symposium Proceedings, Amsterdam. Holland, pp. 78.
140. Senderowicz AM, Headlee D, Lush R, Bauer K, Figg W, Murgo AS, Arbuck S, Inoue K, Kobashi S, Kuwabara T and Sausville E. (1999). Proceedings of the Thirty-fifth Annual Meeting of the American Society of Clinical Oncology Vol. 18, Atlanta, GA.
141. Senderowicz AM, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Steinberg SM, Figg WD, Tompkins A, Arbuck SG and Sausville EA. (1998b). J. Clin. Oncol., 16, 2986-2999.
142. Senderowicz AM, Messmann R, Arbuck S, Headlee D, Zhai S, Murgo A, Melillo G, Figg W and Sausville E. (2000). Proceedings of the Annual Meeting of the American Society of Clinical Oncology, New Orleans.
143. Senderowicz AM and Sausville EA. (2000). J. Natl. Cancer Inst., 92, 376-387.
144. Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA and Worland PJ. (1994). Mol. Pharmacol., 45, 1207-1214.
145. Seynaeve CM, Stetler-Stevenson M, Sebers S, Kaur G, Sausville EA and Worland PJ. (1993). Cancer Res., 53, 2081-2086.
146. Shao RG, Cao CX, Shimizu T, O'Connor PM, Kohn KW and Pommier Y. (1997). Cancer Res., 57, 4029-4035.
147. Shapiro GI, Koestner DA, Matranga CB and Rollins BJ. (1999b). Clin. Cancer Res., 5, 2925-2938.
148. Shapiro G, Patterson A, Lynch C, Lucca J, Anderson L. Boral A, Elias A, Lu H, Salgia R, Skarin A, Panek-Clark C, McKenna R, Rabin M, Vasconcelles M, Eder P, Supko J, Lynch T and Rollins B. (1999a). Proceedings of the American Society of Clinical Oncology Vol. 18, Atlanta, GA.
149. Shapiro GI, Supko JG, Patterson A, Lynch C, Lucca J, Zacarola PF, Muzikansky A, Wright JJ, Lynch Jr TJ and Rollins BJ. (2001). Clin. Cancer Res., 7, 1590-1599.
150. Sherr CJ. (1996). Science, 274, 1672-1677.
151. Shimizu E, Zhao MR, Nakanishi H, Yamamoto A, Yoshida S, Takada M, Ogura T and Sone S. (1996). Oncology, 53, 494-504.
152. Sielecki TM, Johnson TL, Liu J, Muckelbauer JK, Grafstrom RH, Cox S, Boylan J, Burton CR, Chen H, Smallwood A, Chang CH, Boisclair M, Benfield PA, Trainor GL and Seitz SP. (2001). Bioorg. Med. Chem. Lett., 11, 1157-1160.
153. Soni R, Muller L, Furet P, Schoepfer J, Stephan C, Zumstein-Mecker S, Fretz H and Chaudhuri B. (2000). Biochem. Biophys. Res. Commun., 275, 877-884.
154. Soni R, O'Reilly T, Furet P, Muller L, Stephan C, Zumstein-Mecker S, Fretz H, Fabbro D and Chaudhuri B. (2001). J. Natl. Cancer Inst., 93, 436-446.
155. Sonoda Y, Yoshimoto T and Sekiya T. (1995). Oncogene, 11, 2145-2149.
156. Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA and Cristiano RJ. (1996). Anticancer Res., 16, 3415-3422.
157. Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz D and Vokes EE. (2000). J. Clin. Oncol., 18, 371-375.
158. Sugiyama K, Shimizu M, Akiyama T, Tamaoki T, Yamaguchi K, Takahashi R, Eastman A and Akinaga S. (2000). Int. J. Cancer., 85, 703-709.
159. Takahashi I, Kobayashi E, Asano K, Yoshida M and Nakano H. (1987). J. Antibiot (Tokyo), 40, 1782-1784.
160. Takahashi I, Saitoh Y, Yoshida M, Sano H, Nakano H, Morimoto M and Tamaoki T. (1989). J. Antibiot (Tokyo), 42, 571-576.
161. Tamaoki T. (1991). Methods Enzymol., 201, 340-347.
162. Tamura T. Sasaki Y, Minami H, Fujii H, Ito K, Igarashi T, Kamiya Y, Kurata T. Ohtsu T, Onozawa Y, Yamamoto N, Yamamoto N, Watanabe Y, Tanigaara Y, Fuse E, Kuwabara T, Kobayahsi S and Shimada Y. (1999). Proc. Am. Soc. Clin. Oncol., 18, 159.
163. Tan AR, Headlee D, Messmann R, Sausville EA, Arbuck SG, Murgo AJ, Melillo G, Zhai S, Figg WD, Swain SM and Senderowicz AM. (2002). J. Clin. Oncol., 20, 4074-4082.
164. Testa JR and Bellacosa A. (2001). Proc. Natl. Acad. Sci. USA, 98, 10983-10985.
165. Thomas JP, Tutsch KD, Cleary JF, Bailey HH, Arzoomanian R, Alberti D, Simon K, Feierabend C, Binger K, Marnocha R, Dresen A and Wilding G. (2002). Cancer Chemother. Pharmacol., 50, 465-472.
166. Tsuchida E and Urano M. (1997). Int. J. Radiat. Oncol. Biol. Phys., 39, 1153-1161.
167. Usuda J, Saijo N, Fukuoka K, Fukumoto H, Kuh HJ, Nakamura T, Koh Y, Suzuki T, Koizumi F, Tamura T, Kato H and Nishio K. (2000). Int. J. Cancer, 85, 275-280.
168. Walker DH. (1998). Curr. Top. Microbiol. Immunol. 227, 149-165.
169. Wang MB, Billings KR, Venkatesan N, Hall FL and Srivatsan ES. (1998). Otolaryngol. Head Neck Surg., 119, 593-599.
170. Wang C. Fu M, Mani S, Wadler S, Senderowicz AM and Pestell RG. (2001). Front. Biosci., 6, D610-D629.
171. Wang Q, Fan S, Eastman A. Worland PJ. Sausville EA and O'Connor P. (1996). J. Natl. Cancer Inst., 88, 956-965.
172. Wang Q. Worland PJ, Clark JL, Carlson BA and Sausville EA. (1995). Cell Growth Differ., 6, 927-936.
173. Warbrick E, Lane DP, Glover DM and Cox LS. (1995). Curr Biol., 5, 275-282.
174. Weinberg RA. (1996). Cytokines Mol. Ther., 2, 105-110.
175. Werner J, Kelsen D, Karpeh M, Inzeo D, Barazzuol J, Sugarman A and Schwartz GK. (1998). Proceedings of the American Society of Clinical Oncology Vol. 17, Los Angeles, CA.
176. Wilcken NR, Sarcevic B, Musgrove EA and Sutherland RL. (1996). Cell Growth Differ., 7, 65-74.
177. Wilson WH, Sorbara L, Figg WD, Mont EK, Sausville E, Warren KE, Balis FM, Bauer K, Raffeld M, Senderowicz AM and Monks A. (2000). Clin. Cancer Res., 6, 415-421.
178. Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De Plaen E, Hankein T, Meyer zum Buschenfelde KH and Beach D. (1995). Science, 269, 1281-1284.
179. Worland PJ, Kaur G, Stetler-Stevenson M, Sehers S, Sartor O and Sausville EA. (1993). Biochem. Pharmacol., 46, 1831-1840.
180. Wright J, Blatner GL and Cheson BD. (1998). Oncology (Huntingt), 12 1018, 1023-1024.
181. Yu JT, Foster RG and Dean DC. (2001). Mol. Cell. Biol., 21, 3325-3335.
182. Yu L, Orlandi L, Wang P. Orr M, Senderowicz AM, Sausville EA, Silvestrini Ra and O'Connor P. (1998). J. Biol. Chem., 273, 33455-33464.
183. Zaharevitz DW, Gussio R, Leost M, Senderowicz AM, Lahusen T, Kunick C, Meijer L and Sausville EA. (1999). Cancer Res., 59, 2566-2569.
184. Zhou Q, Stetler-Stevenson M and Steeg PS. (1997). Oncogene, 15, 107-115.
185. Zhu G, Conner S, Zhou X, Shih C, Brooks HB, Considine E, Dempsey JA, Ogg C, Patel B, Schultz RM, Spencer CD, Teicher B and Watkins SA. (2003 a). Bioorg. Med. Chem. Lett., 13, 1231-1255.
186. Zhu G, Conner SE, Zhou X, Shih C, Li T, Anderson BD, Brooks HB, Campbell RM, Considine E, Dempsey JA, Faul MM, Ogg C, Patel B, Schultz RM, Spencer CD, Teicher B and Watkins SA. (2003b). J. Med. Chem., 46, 2027-2030.